The Kaposi's Sarcoma associated Herpes virus (KSHV) encodes two genes with the potential to aect the activity of the retinoblastoma protein (Rb). Open reading frame (orf) 72 encodes a D type cyclin (kcyc) that can elicit p16INK4a resistant cdk activity and orf73 encodes the latency associated nuclear antigen (LNA) that can bind Rb and neutralize E2F regulation. This indicates that, like papilloma and adenovirus associated malignancies, those associated with KSHV are defective with respect to their Rb pathway. To address this we investigated whether KSHV associated primary eusion lymphoma (PEL) derived cell lines are resistant to growth inhibition by p16INK4a. We provide evidence that ectopic expression of p16INK4a in these cells causes an Rb dependent G1 cell cycle block. Importantly, endogenous p16INK4a expression is not detected in six PEL derived cell lines and four primary PEL samples and examination of the p16INK4a locus shows deletion in two out of six and hypermethylation in four out of six PEL lines. Treatment of the latter with the demethylating agent 5'-aza-2' deoxycytidine leads to re-expression of p16INK4a protein. Taken together these results suggest that p16INK4a loss may be a cellular change frequently associated with PEL. They furthermore argue that despite the presence of KSHV DNA and expression of a latent gene program Rb function is intact in PEL. Oncogene (2002) 21, 1823 ± 1831. DOI: 10.1038/sj/ onc/1205360
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Introduction
Cell cycle regulation requires the ordered activation of cyclin dependent kinases (cdks). The cell cycle transition from G1 into S phase is regulated by cyclin D dependent kinases cdk4 and cdk6 and later by cyclin E/cdk2 kinase complexes. These cdks phosphorylate the Rb tumour suppressor allowing release of E2F transcription factors and subsequent expression of E2F dependent genes required for S phase. Negative regulation of cdks occurs by the action of two classes of cdk inhibitors (CDIs) (reviewed Sherr and Roberts, 1999) . The KIP/CIP family, exempli®ed by p21CIP, p27KIP and p57KIP2, inhibit cyclin E and cyclin A dependent kinases and at a higher concentration also cyclin D dependent kinases. The second class, the INK4 family are speci®c inhibitors of cyclin D dependent kinases and includes p16INK4a, p15INK4b, p18INK4c and p19INK4d. The ability of the p16INK4a protein to promote G1 phase cell cycle arrest absolutely depends upon the presence of functional Rb (Lukas et al., 1995; Medema et al., 1995) and Rb phosphorylation by cdk4 and cdk6 kinases is rate limiting for cell cycle progression.
Mis-regulation of the Rb/p16INK4a pathway is one of the most common events in human cancer. p16INK4a is a suspect tumour suppressor gene that undergoes deletion, mutation and CpG promoter methylation in an extremely wide spectrum of tumours, including many lymphoid malignancies. Homozygous deletion of p16INK4a occurs in acute lymphoblastic leukaemia (Hangaishi et al., 1996; Hebert et al., 1994) , adult T cell leukaemia (Hatta et al., 1995; Yamada et al., 1997) and chronic myeloid leukaemia (Sill et al., 1995) . CpG methylation, resulting in silencing of p16INK4a transcription, frequently occurs in highgrade non-Hodgkin's lymphoma (Pinyol et al., 1998; Villuendas et al., 1998) , mucosa associated lymphoid tissue lymphoma (MALT) and Burkitt's lymphoma (Klangby et al., 1998) .
Kaposi's sarcoma associated herpes virus (KSHV) or human herpesvirus 8 (HHV-8), a type 2 gamma herpesvirus is associated with Kaposi's sarcoma (Chang et al., 1994) , primary eusion lymphoma, a rare B cell lymphoma occurring with HIV infection (Cesarman et al., 1995a; Gessain et al., 1997) and a plasmablastic variant of multicentric Castleman's disease (Soulier et al., 1995) . KSHV encodes proteins with the potential to aect cell cycle control by the Rb/ p16INK4a pathway. One of these is a protein with similarity to D-type cyclins (kcyc) Chang et al., 1996; Godden-Kent et al., 1997) featuring a number of unusual biochemical characteristics. Most notably, in cell culture systems kcyc forms active complexes with cdk6 which are resistant to inhibition by the cdk inhibitors p27, p21 and p16INK4a (Swanton et al., 1997) this leading to the suggestion that expression of kcyc confers resistance to the antiproliferative action of these cdk inhibitors. Another is the major latency associated nuclear antigen, LNA (Kellam et al., 1997; Rainbow et al., 1997) . LNA has been shown to interact with both p53, repressing p53 mediated transcriptional activity and apoptosis (Friborg et al., 1999) and Rb, activating E2F mediated transcription (Radkov et al., 2000) . Thus, KSHV, like small DNA viruses of the adeno-, polyoma and papilloma virus group appears to have evolved mechanisms to co-ordinately inactivate the INK4a/Rb and ARF/p53 tumour suppressor pathway. While changes aecting gene expression in these pathways frequently occur in cancers, they are usually not found in tumours associated with the small DNA viruses (Kelley et al., 1995; Wrede et al., 1991) . To address whether the same applies to KSHV we examined the expression of retinoblastoma protein and its regulator p16INK4a in KSHV associated PEL. We provide evidence for absence of protein expression and inactivation of the p16INK4a locus. In addition we demonstrate sensitivity of PEL derived cell lines to the growth inhibitory eects of p16INK4a. This suggests that retinoblastoma function is retained and that absence of p16INK4a function may be a critical requirement to override cellular growth control in these tumours.
Results

Loss of p16INK4a expression in primary effusion lymphoma cell lines
To investigate whether the p16INK4a/Rb tumour suppressor pathway is aected in PEL through changes aecting expression of their encoding genes we performed Western blot analysis on lysate prepared from a panel of six PEL derived cell lines: BCP-1, BC-3, ISI-1, Cro-Ap/6, HBL-6 and BCBL-1. Figure 1 shows that full-length Rb was detectable in ®ve of the PEL cell lines (top, lanes 4 ± 8, BCBL-1, BCP-1, ISI-1, HBL-6 and Cro-Ap/6), but could not be detected in BC-3 cells (lane 3). p16INK4a expression was not apparent in any of the PEL cell lines (Figure 1 , middle, lanes 3 ± 8) but was detected in two positive control cell lines, Hacat (lane 1) and SAOS2, an osteosarcoma cell line that lacks wild-type Rb expression (lane 2). This suggests that while loss of Rb expression is infrequent, expression of p16INK4a may be widely impaired in PEL.
p16INK4a is commonly inactivated by mutation, homozygous deletion or CpG methylation in a variety of lymphomas (Baur et al., 1999) . To investigate whether CpG methylation of the p16INK4a regulatory sequences could account for loss of p16INK4a expression in PEL cell lines methylation speci®c PCR (MSP) was performed on sodium bisul®te treated genomic DNA, using primers recognizing either unmethylated (U) or methylated (M) p16INK4a DNA ( Figure 2a ). In addition a pair of osteosarcoma cell lines, U2OS and SAOS2, which contain a methylated and unmethylated p16 INK4a locus respectively were used as controls. Control cell lines produced ampli®cation products in accordance with the published methylation status of the p16INK4A locus (Stott et al., 1998) . Four of the six cell lines, BCP-1, ISI-1, BCBL-1 and HBL-6, produced a p16INK4a ampli®cation product with M but not U primers, indicating that the p16INK4a promoter and 5' exon sequences are methylated in these cell lines. The remaining two cell lines, BC-3 and Cro-Ap/6, failed to produce a PCR product with either U or M primers, suggesting that p16INK4a may be deleted in these cell lines. To address this possibility genomic DNA from Cro-Ap/6 and BC-3 cells was ampli®ed with wild-type (w) primers, which recognize the p16INK4a gene sequence in non-bisul®te treated DNA. Whereas p16INK4a could be ampli®ed from BCP-1 control DNA no ampli®cation product could be produced from Cro-Ap/6 or BC-3 DNA, indicating that homozygous deletion of p16INK4a had occurred ( Figure 2b , lanes 1 ± 4). All three-cell lines produced a signal when ampli®ed with GAPDH primers con®rm-ing the integrity of the genomic DNA ( Figure 2b , lanes 5 ± 8).
Taken together these results indicate that the p16INK4a locus has suered inactivating events, either by CpG methylation or homozygous deletion, in all of the primary eusion lymphoma cell lines tested. To address whether p16INK4a expression is compromised in primary PEL tumours, protein lysate Figure 3 (upper panel) shows that at this cell number p16INK4a protein could be readily detected in SAOS2 cells but could not be detected in the PEL samples. This suggests that p16INK4a expression is either absent or at very low levels in primary eusion lymphoma.
5-aza-2'deoxycytidine treatment of PEL cell lines
To investigate whether methylation of the p16INK4a promoter, detected in a proportion of the PEL cell lines, prevents expression from the p16INK4a locus we assessed whether p16INK4a protein can be reexpressed in these cell lines following treatment with the DNA methylase inhibitor 5-aza-2'deoxycytidine (5azacdr). Treatment of cells with this or similar demethylating agents has previously been shown to restore expression of p16INK4a where the promoter was silenced by hypermethylation (Merlo et al., 1995; Otterson et al., 1995) .
Three PEL cell lines BCBL-1, HBL-6 and ISI-1, containing hypermethylated p16 locus and one cell line, Cro-Ap/6, in which the p16INK4a locus is deleted, were treated with 3 and 5 mM 5azacdr for 4 days and p16INK4a expression was assessed by Western blot analysis. Accumulation of the p16INK4a protein is detected in BCBL-1 and HBL-6, with both doses of 5azacdr ( Figure 4 , upper panels). It should be noted Figure 2 Inactivation of the p16INK4a gene. (a) CpG methylation of the p16INK4a gene. Genomic DNA was prepared from the six PEL cell lines. PCR was performed on sodium bisul®te treated genomic DNA using primers that speci®cally recognize either methylated (M) or unmethylated (U) p16INK4a (Intergen). Modi®ed genomic DNA prepared from two osteosarcoma cell lines U2OS and SAOS2 were included as controls for methylated and unmethylated p16INK4a promoter respectively and in addition methylated (control M) or unmethylated (control U) DNA from the CpG Wiz PCR ampli®cation kit (Intergen) were included. (b) Deletion of the p16INK4a gene. PCR was performed on unmodi®ed genomic DNA prepared from BC-3, Cro-Ap/6 and BCP-1 cells using primers recognizing positions close to the p16INK4a transcriptional start site (Intergen) (lanes 2 ± 4). To con®rm the integrity of the DNA PCR was performed using GADPH primers (lanes 5 ± 8) Figure 3 p16INK4a expression in PEL biopsies. Western blot analysis was performed using protein lysates prepared from four acetone-chloroform ®xed cytospins from PEL clinical samples. As a control for detection of p16INK4a 10 4 and 10 5 SAOS2 cells were loaded. To control for protein loading blots were stained with amido black and the intensity of bands in the region of 14.3 ± 21.5 kD were compared
Figure 4 5-aza-2'deoxycytidine treatment of PEL cells. Four PEL cell lines BCBL-1, HBL-6, ISI-1 and Cro-Ap/6 were treated with 3 or 5 mM 5-aza-2'deoxycytidine for 4 days or left untreated. Cell lysates, prepared in HB buer, were analysed by Western blotting for expression of p16INK4a protein that only partial demethylation of the p16INK4a promotor could be achieved in these cell lines as assessed by methylation sensitive PCR (data not shown). Much lower levels of p16INK4a protein were observed in ISI cells treated with 5 mM 5azacdr ( Figure  4 , lower panel, left), suggesting that demethylation occurred less eciently in this cell line. As expected 5azacdr treatment of Cro-Ap/6 cells, in which the p16INK4a locus is deleted, did not lead to detection of p16INK4a protein (Figure 4, lower panel, right) . These results establish an association between CpG methylation and transcriptional silencing of p16INK4a in PEL cell lines.
Sensitivity of PEL cell lines to p16INK4a
The results presented above indicate that silencing of the p16INK4a locus by genetic or epigenetic means is a frequent event in PEL, which might be necessary in order to retain the proliferative potential of these cells. However in the light of previous studies demonstrating that the two Rb inactivating proteins, kcyc and LNA-1, are expressed in PEL derived cell lines and primary PEL (Carbone et al., 2000b; Dupin et al., 1999; Platt et al., 2000; Rainbow et al., 1997) , these cells may not be sensitive to the growth inhibitory eects of p16INK4a. Experiments described above demonstrated p16INK4a re-expression induced by 5azacdr treatment. However, analysis of 5azacdr treated PEL cells indicated that proliferation was severely aected at time points and concentrations where p16INK4a expression was undetectable and in cells that had suered deletion of p16INK4a, thus precluding conclusions as to the biological eects of p16INK4a expression based on these experiments.
To assess whether principally p16INK4a can play a role in controlling PEL proliferation we investigated the eects of recombinant adenovirus, expressing human p16INK4a and GFP, which facilitates detection of transduced cells.
Two of the six PEL cell lines, the Rb negative BC-3 and Rb positive BCBL-1, were found to be eciently transduced using an empty GFP tagged adenovirus (30% and 5 ± 10% transduction respectively). We therefore selected these two cell lines for further study of p16INK4a sensitivity. As a control the osteosarcoma cell line U2OS, known to be sensitive to the growth inhibitory eects of p16INK4a was also included for comparison of p16INK4a sensitivity (Lukas et al., 1995; Medema et al., 1995) . Western blot analysis of transduced BC-3 demonstrates that the levels of adenovirally expressed p16INK4a (Figure 5a , left panel, lane 1) are similar to those present in SAOS2 cells (left panel, lane 4) and thus, that in PEL cells this virus directs synthesis of p16INK4a levels within the physiological range. In contrast higher levels of p16INK4a expression were achieved in U2OS cells (Figure 5a, right panel) .
To investigate whether p16INK4a has growth inhibitory eects in PEL cells, BCBL-1 and BC-3 cells were infected with either an empty adenovirus or adenovirus directing the expression of p16INK4a. The cell cycle position of GFP positive cells was determined by FACS analysis. Figure 5b illustrates that transduction of BCBL-1 cells with p16INK4a adenovirus resulted in a strong increase in cells in the G1 compartment when compared to cells transduced with empty virus (53.5% compared to 22%, Figure 5b , left panel). Transduction of U2OS cells with the p16 adenovirus resulted in 67% of the cells accumulating in the G1 phase (Figure 5b, right panel) , indicating that although these cells express signi®cantly more p16, their growth is only slightly more inhibited by p16INK4a than the PEL cells. In contrast, transduction of Rb negative BC-3 cells with the p16INK4a adenovirus resulted in only a small response (34% compared to 28%). These results indicate that adenovirus mediated expression of p16INK4a causes growth inhibition of BCBL-1 cells but has considerably less eect on Rb negative BC-3 cells. To assess whether absence of Rb expression is responsible for the relative resistance of BC-3 cells we assessed the ability of ectopic Rb expression to restore p16INK4a sensitivity in these cells using plasmid cotransfection. BC-3 cells were transfected with plasmids expressing p16INK4a and human Rb along with the CD20 cell surface marker to allow detection of transfected cells. As controls Rb or p16INK4a alone or the equivalent empty plasmids were transfected. Figure 5c illustrates that there is a signi®cant accumulation of cells in the G1 phase of the cell cycle in the presence of both Rb and p16INK4a (47%) compared with the presence of Rb or p16INK4a alone (24.5 and 23.4% respectively), or empty vector (15%). Although expression of the p16INK4a or Rb plasmids alone in BC-3 cells causes a small G1 delay compared with empty vector, this eect is greatly enhanced in the presence of both Rb and p16INK4a, indicating that the G1 arrest imposed by p16INK4a in these cells is Rb dependent.
kcyc cdk complexes from a PEL cell line are insensitive to p16INK4a
To assess whether the growth inhibitory eect of p16INK4a in PEL could be linked to the p16INK4a sensitivity of kcyc/cdk complexes in these cells we performed kinase assays using immunopuri®ed PEL derived kcyc associated kinase. Although it is well established that recombinant kcyc/cdk6 complexes are resistant to inhibition by p16INK4a this has not been con®rmed for kcyc activity from non-recombinant source. Since BC-3 cells express high amounts of kcyc (Platt et al., 2000) these cells were used to isolate kcyc associated kinase activity by immunoprecipitation using a kcyc speci®c antibody. The ability of these complexes to phosphorylate the carboxy terminus of Rb in the presence of increasing amounts of recombinant p16INK4a was tested. Lysate prepared from insect cells directing the expression of baculovirus produced cyclin D1 cdk4 complexes was used as a control for p16INK4a activity. Figure 6 shows that the kinase activity of baculovirus expressed cyclin D1/cdk4 complexes was completely inhibited in the presence of 100 ng recombinant p16INK4a (lane 13). In contrast p16INK4a loss in PEL G Platt et al the kinase activity associated with BC-3 derived kcyc was unaected by 100 ng of p16INK4a (lane 4). These results demonstrate that in agreement with data based on recombinantly expressed kcyc/cdk6, naturally expressed kcyc/cdk complexes from BC-3 cells are insensitive to p16INK4a. This indirectly implies that cyclin D dependent cdks but not kcyc-cdk complexes are the target of ectopically expressed p16INK4a in PEL cells.
Discussion
Mutations within the retinoblastoma protein pathway aecting either Rb or its upstream regulator p16INK4a are commonly found in human malignancies and loss of this pathway appears to be an important event in tumour development. Several DNA tumour viruses interfere with this pathway by encoding proteins that inactivate Rb. Evidence suggests that KSHV has evolved mechanisms to inactivate Rb through the action of a cyclin which forms a p16INK4a resistant Rb kinase (Swanton et al., 1997) and LNA the product of the latency associated open reading frame 73, which has been reported to bind and neutralize Rb function (Radkov et al., 2000) . Characteristically, Rb and p16INK4a are found in wild-type con®guration in tumours associated with Rb inactivating DNA tumour viruses (Kelley et al., 1995; Wrede et al., 1991) and Rb expression combined with high levels of p16INK4a expression are often observed in these tumours (Kelley et al., 1995; Klaes et al., 2001) . Using primary eusion lymphoma derived cell lines as a model we have addressed whether genetic changes occur in the Rb/ p16INK4a pathway in KSHV-associated tumours. We ®nd lack of p16INK4a expression combined with genetic or epigenetic events known to aect expression of the p16INK4a protein in six out of six PEL cell lines. This argues that the p16-encoding locus is a target for inactivation in these cultured cells. The absence of p16INK4a expression in primary isolates indicates that this may also be true in primary PEL. However, due to the limited availability of primary material genomic analysis of the locus was not possible. Expression of p16INK4a has previously been shown to be aected in several types of lymphoma (reviewed Drexler, 1998) . In a comprehensive study of nonHodgkin's lymphoma's (NHL) inactivation of p16INK4a was associated with aggressive variants of the disease (Pinyol et al., 1998) . p16INK4a gene alterations by homozygous deletions, point mutations or methylation were detected in 33% of primary highgrade and transformed lymphomas but in only 5% of indolent tumours, leading to the suggestion that inactivation of this gene may participate in the development of primary aggressive and progressed lymphomas (Pinyol et al., 1998) . The incidence of p16INK4a loss found in lymphoma derived cell lines is frequently higher than in primary clinical samples. For example, p16INK4a was found to be methylated in 89.5% of Burkitts lymphoma derived cell lines but in only 42% of primary tumours (Klangby et al., 1998) . By analogy, although defects in p16INK4a are found in a very high proportion of PEL-derived lines they may occur less frequently in primary material. Studies of other leukaemia-lymphomas involving analysis of cell lines alongside primary material from which the cell lines were derived demonstrated concordant loss in the majority of cases (reviewed Drexler, 1998) . This suggests that p16INK4a alterations in cell lines may be a valid indication for the presence of these lesions in the corresponding primary tumour.
In addition to the very frequent alterations in p16INK4a we report loss of Rb expression in one of the PEL cell lines. Thus, genetic events aecting Rb expression may occur at low frequency in PEL. Loss of Rb expression is not infrequent in lymphoma but is usually associated with deletions extending into loci telomeric to the Rb gene (reviewed Liu et al., 1995) . This, along with other evidence, including the absence of point mutations in Rb itself and the occurrence of gene loss at 13q14 that does not aect the Rb reading frame has suggested that a tumour suppressor other than Rb may be encoded at this locus. Our ®nding could indicate that loss of this 13q14 encoded tumour suppressor arises in PEL albeit at low frequency.
The limited genetic analysis so far available indicates that PEL does not have molecular alterations usually associated with B type NHL, including translocations involving BCL2, BCL6, c-myc or mutations in p53 (reviewed Drexler et al., 1998) . Mutations in the 5' non-coding region of BCL6 occur with high frequency, as does complete or partial trisomy 12 and trisomy 7 (Gaidano et al., 1999) . The work presented here adds p16INK4a to the list of potential genetic lesions associated with PEL.
We also provide evidence that PEL-derived cell lines are sensitive to p16INK4a and that this, as in other cell systems, relies on RB expression (Lukas et Figure 6 The p16INK4a resistance of kcyc/cdk complexes from BC-3 cells. Lysate prepared from BC-3 cells was pre-cleared twice with sheep serum and immunoprecipitated with either sheep anti kcyc antiserum or sheep serum. The kinase activity associated with the immunoprecipitated kcyc/cdk complexes was assayed in the presence of increasing amounts of p16INK4a using a carboxy terminal fragment of Rb (amino acids 763 to 928) fused to GST as a substrate. SF9 lysate expressing baculovirus encoded cyclin D1 and cdk4 was used to control for p16INK4a inhibition (cdk4 only was included as a background control). The amount of recombinant p16INK4a added to each reaction is as follows: no p16INK4a (lanes 1, 5, 10), 25 ng (lanes 2, 6, 11) 50 ng (lanes 3, 7, 12) and 100 ng (lanes 4, 8, 13) p16INK4a loss in PEL G Platt et al al., 1995; Medema et al., 1995) . This has several important implications as to the mechanism by which KSHV genes contribute to PEL oncogenesis. It ®rstly infers that the p16INK4a resistant kinase associated with kcyc does not confer p16INK4a resistant growth to these cells. It secondly argues that the retinoblastoma protein is operational in these cells. Both these implications challenge predictions based on ectopic expression of recombinant kcyc and LNA-1 in tissue culture cells (Godden-Kent et al., 1997; Radkov et al., 2000; Swanton et al., 1997) , where either one of these gene functions can neutralize the antiproliferative function of Rb. kcyc and LNA-1 have been shown to be expressed in all PEL lines used here (Carbone et al., 2000b; Platt et al., 2000; Rainbow et al., 1997) , and we provide evidence that the enzymatic activity associated with kcyc in PEL is p16INK4a resistant. Thus absence or altered activity of these viral proteins is not the explanation for the con¯icting results.
It has been noted that in vitro, under conditions where time or enzyme amount is limiting, kcyc associated kinase complexes phosphorylate only a subset of the phosphorylation sites present in Rb Child and Mann, 2001) . It is however possible that under conditions of overexpression, following ectopic expression from plasmid vectors, such site restriction is overcome leading to a more complete RB phosphorylation. The level of kcyc naturally expressed in PEL may be too low to function by this mode and in this circumstance may require cooperation with p16 sensitive cyclin D kinase to complete Rb phosphorylation. Though it is clear from previous work that the level of kcyc expression varies between PEL derived cell lines (Platt et al., 2000) , the absolute amount in a given cell is not known. A similar scenario may apply for LNA-1. LNA-1 has been proposed to impair Rb function by binding to Rb. While principally competent to do so its expression levels in PEL may not be sucient for stoichiometric sequestration of Rb. These arguments raise the possibility that KSHV, while principally able to aect the Rb pathway, may not do so unless conditions arise where expression levels of the Rb inactivating function(s) is sucient.
Materials and methods
Primary effusion lymphoma cell lines (PELS)
Primary eusion lymphoma derived cell lines BC-3 (Arvanitakis et al., 1996) , HBL-6/BC-1 (Cesarman et al., 1995b) , ISI-1 (Oksenhendler et al., 1998) , BCBL-1 (Kedes et al., 1997) , BCP-1 (Bosho et al., 1998) and Cro-Ap/6 (Carbone et al., 2000a) were obtained from E Cesarman (Cornell University, NY, USA), C Bosho (UCL London, UK), F Agbalika (Hopital Saint-Louis, Paris, France), T Schulz (Medical School, Hannover, Germany) and G Gaidano (National Tumour Institute, Italy).
All PEL cell lines were maintained in RPMI 1640 medium supplemented with 15% foetal calf serum (FCS). SAOS2 and Hacat cells were maintained in DMEM supplemented with 10% FCS.
Immunoprocedures
Cell lysate were prepared in HB buer (50 mM HEPESNaOH pH 7.4, 150 mM NaCl, 20 mM EDTA, 0.5% Triton X-100, 2 mM DTT, 10 mM B-glycerophosphate) at a concentration of 2610 7 cells/ml. Two610 5 cells were loaded per lane and analysed by Western blotting according to standard techniques. Blots were probed with p16INK4a (DCS 50.1 Santa Cruz) and Rb (14001A Pharmingen) antibodies and proteins were detected using horseradish peroxidase conjugate secondary antibodies and the ECL detection system (Amersham). As a loading control blots were probed with anti-tubulin antibody (DM1B, Neomarkers).
Four PEL clinical samples were obtained as acetonechloroform ®xed cytospin preparations (Carbone et al., 2000c) . Protein lysate was prepared by the addition of 30 ml Laemmli buer to each cytospin specimen. After 10 min at room temperature the lysate was recovered, boiled for 3 min and analysed by Western blotting. To assess protein loading ®lters were stained with amido black (0.1% w/v amido black (Sigma) 10% acetic acid, 25% isopropanol).
Insect cell culture and the production of recombinant protein by baculovirus have been described (Godden-Kent et al., 1997).
Methylation specific PCR (MSP)
Genomic DNA was prepared using the Easy-DNA kit (Invitrogen) according to the manufacturer's instructions. DNA was modi®ed with sodium bisul®te using the CpGenome DNA modi®cation kit (Intergen) according to the manufacturer's instructions. Sodium bisul®te modi®ca-tion converts cytosine into uracil but leaves methylcytosine unaltered. Bisul®te modi®ed DNA was ampli®ed using primers that recognize unmethylated (U) or methylated (M) sequence. Unmodi®ed DNA was ampli®ed with wildtype (W) p16INK4a primers. U, M and W primers and control U and M DNA were supplied in the CpG Wiz p16INK4a ampli®cation kit (Intergen). 5' primers lie close to the p16INK4a transcriptional start site. All ampli®cation was carried out using hot start and Platinum Taq polymerase (Gibco ± BRL) using the following conditions: 958C 2 min 30 s 1 cycle; 958C 45 s, 608C 45 s, 728C 60 s, 35 cycles. PCR products were analysed on 2% agarose gels. To con®rm the integrity of genomic DNA PCR ampli®cation using GAPDH primers F 5'-AACATCATCCCTGCCTC-TACTG-3' R 5'-TTGACAAAGTGGTCGTTG AGG-3' was performed under the following conditions; 948C 30 s, 578C 30 s, 728C 30 s.
Recombinant adenoviruses
GFP tagged recombinant adenoviruses were constructed by homologous recombination in E. coli and packaged and ampli®ed in 293 cells according to published methods (He et al., 1998) . The pAdtrack-KS17 shuttle vector and Adeasy-1 adenoviral plasmid were obtained with the permission of B Vogelstein (Johns Hopkins Oncology Center, Baltimore, MD, USA). A 0.6 kB BamHI ± EcoRI fragment from pcDNA3-p16INK4a (a gift from G Peters, ICRF, London), containing the p16INK4a open reading frame was cloned into the BamHI and EcoRI sites of the pAdtrack-KS17 shuttle vector. Transfection and cell cycle analysis of PEL cells
One610
6 BC-3 cells were transfected with a total of 2 mg of DNA containing 0.33 mg pcDNA3-p16INK4a, 0.33 mg pTRE-Rb, 1 mg pTeto, 0.33 mg pCMV-CD20 or 0.33 mg of the corresponding empty plasmids pcDNA3 and pTre using Transfast (Promega) according to the manufacturer's instructions. Forty-eight hours post transfection cells were treated with 400 ng/ml nocodazole for 16 h. Cells were stained with CD20-FITC conjugated antibody (Becton Dickinson) and 40 mg/ml propidium iodide, and analysed by FACS (FACScan).
5-aza-2'-deoxycytidine treatment
Cells at a concentration of 5610 4 /ml were untreated or treated with 5-aza-2'-deoxycytidine at a ®nal concentration of 3 or 5 mM for 96 h. Cells were harvested, counted and resuspended in ELB buer (250 mM NaCl, 50 mM HEPES-KOH, 5 mM EDTA, 10 mM b-glycerophosphate, 10 mM NaF, 1 mM NaVO 3 , 0.2% Triton X-100, 1 mM DTT, 10 mM PMSF) at 2610 7 cells/ml. Lysates were analysed by Western blotting using the p16 (50.1) antibody (Santa Cruz).
Immunoprecipitation and kinase assay of kcyc/cdk complexes Lysate prepared from 1610 7 BC-3 cells in HB buer was pre-cleared twice with sheep serum coated protein A/G beads (Pierce). Pre-cleared serum was immunoprecipitated with protein A/G beads coated with either sheep anti kcyc antibody (ExAlpha Biologicals) or control sheep serum. kcyc/cdk complexes were washed three times with HB buer and once with kinase buer (50 mM HEPES-KOH pH 7.4, 10 mM MnCl 2 , 10 mM MgCl, 10 mM b-glycerophosphate, 1 mM DTT, 0.1 mM protein kinase A inhibitor, 2.5 mg/ml leupeptin, 1% aprotinin, 1 mM PMSF). To assess inhibition by p16INK4a, kcyc/cdk complexes were incubated with 0, 25, 50, or 100 ng of recombinant His tagged p16INK4a (a gift from G Peters, ICRF, London) for 10 min at 278C. An equal volume of reaction mix, containing 500 ng GST-Rb (amino acids 792 ± 928) and 0.2 mCi [g-32 P]ATP was subsequently added and reactions were incubated for 15 min at 278C and stopped by the addition of protein Laemmli buer. One ml of SF9 lysate infected with baculovirus directing the expression of cyclin D1/cdk4 complexes was used as a control for p16INK4a activity.
